About
Accunea is a point-of-care diagnostics company which is developing RenoSure, a medical device capable of detecting critical changes in transplant organ function in real-time, both before and after transplantation. This will enable closer monitoring of kidney transplant patients both pre- and post-operatively to ensure every patient receives a kidney in the best possible condition, and recovers without complications. RenoSure is assisted by AI software which enables early warnings from trend analysis, as well as enabling anonymised data aggregation and analytics for both individual and population-level health.
Technologies
GmailGoogle AppsMicrosoft Office 365Google Cloud HostingGoogle AnalyticsWixMobile FriendlyGoogle Tag ManagerYouTubeVarnishIoT
Keywords
diagnosticsbioengineeringtransplantationkidney functionkidney injurymonitoringbiosensingmedical devicemedical equipment manufacturingrisk assessmentmedical equipment and supplies manufacturingorgan condition monitoringservicesorgan discard reductionclinical insightsmetabolic biomarkersai systemreal-time biomarkershypothermic storage monitoringbiomarker monitoringclinical biomarker supportclinical decision supportb2bmedical devicesbloodless samplingcontinuous samplingpre- and post-transplant monitoringmicrofluidic lab-on-chipmetabolism analysisnormothermic reperfusion
Company Information
- Employees7
- Founded2017
Location
1 Comberton Road, Kidderminster, England, United Kingdom, DY10 1UA
